Merck Keytruda, chemotherapy combination shows mixed results in phase 3 trial for lung cancer Medical Dialogues Bureau7 Jan 2020 9:15 AM ISTWhile the blockbuster drug showed improvement in overall survival for patients treated with Keytruda in combination with chemotherapy, it did not meet...
Drug developers including AstraZeneca, GSK take fresh aim at guided-missile cancer drugs: Report Farhat Nasim7 Jan 2020 9:00 AM ISTThese antibody-drug conjugates, or ADCs, from companies including AztraZeneca and GlaxoSmithKline, are described by researchers as "guided missiles"...
Biocon sells 2.44 pc stake in Biocon Biologics worth Rs 536.25 crore to True North Farhat Nasim6 Jan 2020 4:38 PM IST As per the terms of the proposed agreement, True North will invest Rs 536.25 crore and will eventually translate to a 2.44 per cent minority stake in...
Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected Farhat Nasim6 Jan 2020 1:15 PM ISTNew Delhi: In a major setback to Ranbaxy Laboratories Limited (now Sun Pharmaceutical Industries Ltd.), the Department of Pharmaceuticals (DoP) has...
GPT Pharma Hyderabad unit red-flagged by USFDA for CGMP violations Farhat Nasim6 Jan 2020 10:54 AM ISTIn a warning letter to GPT Pharma's MD Ashok Adityan, USFDA said during inspection of the facility, its investigators observed specific violations,...
Boehringer unveils DiaTEC, a new, proprietary purification technology for PCV2 vaccine Ingelvac CircoFLEX Farhat Nasim6 Jan 2020 9:25 AM ISTEleven years after launching Ingelvac CircoFLEX, researchers of Boehringer Ingelheim developed a process, named DiaTEC, within the current outline of...
Pulmatrix enters kinase inhibitor licensing pact with Lung Cancer Initiative at JnJ Medical Dialogues Bureau6 Jan 2020 9:20 AM ISTThrough the agreement, the Lung Cancer Initiative gains an option to access a portfolio of narrow spectrum kinase inhibitors intended for development...
Mumbai police to like move against Johnson and Johnson over faulty hip implants, says report Farhat Nasim5 Jan 2020 3:05 PM ISTNew Delhi: Johnson and Johnson (JnJ) seems to be in for aome more trouble, as the Mumbai police is about to file a formal case against JnJ's...
WuXi STA Pharma opens oligonucleotide API manufacturing facility in China Medical Dialogues Bureau5 Jan 2020 9:45 AM ISTNew Delhi: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – recently announced the opening of its large-scale oligonucleotide...
Amgen, BeiGene collaborate to expand oncology presence in China Medical Dialogues Bureau5 Jan 2020 9:30 AM ISTNew Delhi: Amgen, recently announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will...
Antabio gets USD 4.4 million funding to develop new treatment for Pseudomonas aeruginosa infections in CF patients Farhat Nasim5 Jan 2020 9:15 AM ISTNew Delhi: Antabio SAS, the biopharmaceutical company focused on developing a broad pipeline of antibacterial treatments against life-threatening WHO...
OPOS, Fullpower enter partnership to create-The First 24/7 Opioid Compliance Solution Medical Dialogues Bureau5 Jan 2020 9:00 AM ISTNew Delhi: Fullpower Technologies, the sleep technology company and OPOS, the opioid optimization company” announced a partnership to create “The...
